A comparison of the fagerström test for cigarette dependence and cigarette dependence scale in a treatment-seeking sample of pregnant smokers

Nicotine and Tobacco Research

Volumn 18, Issue 4, 2016, Pages 477-483

  Berlin, Ivan ^a   Singleton, Edward G ^b   Heishman, Stephen J ^c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Interactive Professional Services   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; NICOTINE GUM;

ADULT; AGE; AREA UNDER THE CURVE; ARTICLE; BEHAVIOR ASSESSMENT; CONSTRUCT VALIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CRONBACH ALPHA COEFFICIENT; DIAGNOSTIC TEST ACCURACY STUDY; FAGERSTROM TEST FOR CIGARETTE DEPENDENCE; FAGERSTROM TEST FOR NICOTINE DEPENDENCE; FEMALE; FIVE ITEM CIGARETTE DEPENDENCE SCALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; INTERNAL CONSISTENCY; MATERNAL SMOKING; MULTICENTER STUDY (TOPIC); MULTIPLE REGRESSION; PARALLEL DESIGN; PREDICTIVE VALIDITY; PREGNANT WOMAN; PRIORITY JOURNAL; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; SALIVA LEVEL; SMOKING CESSATION; SMOKING HABIT; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME; CHEMISTRY; CLINICAL TRIAL; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; MULTICENTER STUDY; PREGNANCY; PROCEDURES; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SALIVA; SMOKING; STANDARDS; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER; TREATMENT OUTCOME;

ADULT; COTININE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; PREGNANCY; REPRODUCIBILITY OF RESULTS; SALIVA; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; SURVEYS AND QUESTIONNAIRES; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 84963864739     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntv108     Document Type: Article

References (49)

1. Fagerström K. Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence. Nicotine Tob Res. 2012;14(1):75-78. doi:10.1093/ntr/ntr137.
2. Fagerström KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav. 1978;3(3-4):235-241.
3. Fagerstrom KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med. 1989;12(2):159-182.
4. Heatherton TF, Kozlowski LT, Frecker RC, Rickert WS, Robinson J. Measuring the heaviness of smoking using self-reported time to first cigarette of the day and number of cigarettes smoked per day. Br J Addict. 1989;84(7):791-799.
5. Piper ME, McCarthy DE, Baker TB. Assessing tobacco dependence:a guide to measure evaluation and selection. Nicotine Tob Res. 2006;8(3):339-351.
6. Etter JF, Le Houezec J, Perneger TV. A self-administered questionnaire to measure dependence on cigarettes: the cigarette dependence scale. Neuropsychopharmacology. 2003;28(2):359-370.
7. Rohsenow DJ, Martin RA, Tidey JW, Monti PM, Colby SM. Comparison of the cigarette dependence scale with four other measures of nicotine involvement: correlations with smoking history and smoking treatment outcome in smokers with substance use. Addict Behav. 2013;38(8):2409-2413. doi:10.1016/j.addbeh.2013.03.019.
8. Stavem K, Røgeberg OJ, Olsen JA, Boe J. Properties of the Cigarette Dependence Scale and the Fagerström Test of Nicotine Dependence in a representative sample of smokers in Norway. Addiction. 2008;103(9):1441-1449. doi:10.1111/j.1360-0443.2008.02278.x.
9. Okuyemi KS, Pulvers KM, Cox LS, et al. Nicotine dependence among African American light smokers: a comparison of three scales. Addict Behav. 2007;32(10):1989-2002.
10. Courvoisier DS, Etter JF. Comparing the predictive validity of five cigarette dependence questionnaires. Drug Alcohol Depend. 2010;107(2-3):128-133. doi:10.1016/j.drugalcdep.2009.09.011.
11. Jaakkola JJ, Gissler M. Maternal smoking in pregnancy as a determinant of rheumatoid arthritis and other inflammatory polyarthropathies during the first 7 years of life. Int J Epidemiol. 2005;34(3):664-671.
12. Zhu JL, Olsen J, Liew Z, Li J, Niclasen J, Obel C. Parental smoking during pregnancy and ADHD in children: the Danish national birth cohort. Pediatrics. 2014;134(2):e382-e388. doi:10.1542/peds.2014-0213.
13. Ekblad M, Gissler M, Lehtonen L, Korkeila J. Prenatal smoking exposure and the risk of psychiatric morbidity into young adulthood. Arch Gen Psychiatry. 2010;67(8):841-849. doi:10.1001/archgenpsychiatry.2010.92.
14. Cornelius MD, Lidush Goldschmidt L, Day NL. Prenatal cigarette smoking:long-term effects on young adult behavior problems and smoking behavior. Neurotoxicol Teratol. 2012;34(6):554-559. doi:10.1016/j. ntt.2012.09.003.
15. Oken E, Levitan EB, Gillman MW. Maternal smoking during pregnancy and child overweight: systematic review and meta-analysis. Int J Obes (Lond). 2008;32(2):201-210. doi:10.1038/sj.ijo.0803760.
16. Nilsson PM, Hofvendahl S, Hofvendahl E, Brandt L, Ekbom A. Smoking in pregnancy in relation to gender and adult mortality risk in offspring:the Helsingborg Birth Cohort Study. Scand J Public Health. 2006;34(6):660-664.
17. Jaddoe VW, de Jonge LL, van Dam RM, et al. Fetal exposure to parental smoking and the risk of type 2 diabetes in adult women. Diabetes Care. 2014;37(11):2966-2973. doi:10.2337/dc13-1679.
18. Doherty SP, Grabowski J, Hoffman C, Ng SP, Zelikoff JT. Early life insult from cigarette smoke may be predictive of chronic diseases later in life. Biomarkers. 2009;14(suppl 1):97-101. doi:10.1080/13547500902965898.
19. Burke H, Leonardi-Bee J, Hashim A, et al. Prenatal and passive smoke exposure and incidence of asthma and wheeze: systematic review and metaanalysis. Pediatrics. 2012;129(4):735-744. doi:10.1542/peds.2011-2196.
20. Thacher JD, Gruzieva O, Pershagen G, et al. Pre- and postnatal exposure to parental smoking and allergic disease through adolescence. Pediatrics. 2014;134(3):428-434. doi:10.1542/peds.2014-0427.
21. Schneider S, Huy C, Schütz J, Diehl K. Smoking cessation during pregnancy:a systematic literature review. Drug Alcohol Rev. 2010;29(1):81-90. doi:10.1111/j.1465-3362.2009.00098.x.
22. Ingall G, Cropley M. Exploring the barriers of quitting smoking during pregnancy: a systematic review of qualitative studies. Women Birth. 2010;23(2):45-52. doi:10.1016/j.wombi.2009.09.004.
23. Dempsey D, Jacob P III, Benowitz NL. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther. 2002;301(2):594-598.
24. Benowitz NL, Hukkanen J, Jacob P III. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol. 2009;192:29-60. doi:10.1007/978-3-540-69248-5_2.
25. Vaz LR, Leonardi-Bee J, Aveyard P, et al. Factors associated with smoking cessation in early and late pregnancy in the smoking, nicotine, and pregnancy trial: a trial of nicotine replacement therapy. Nicotine Tob Res. 2014;16(4):381-389. doi:10.1093/ntr/ntt156.
26. Berlin I, Grangé G, Jacob N, Tanguy ML. Nicotine patches in pregnant smokers: randomised, placebo controlled, multicentre trial of efficacy. BMJ. 2014;348:g1622. doi:10.1136/bmj.g1622.
27. Berlin I, Singleton EG, Heishman SJ. Validity of the 12-item French version of the tobacco craving questionnaire in treatment-seeking smokers. Nicotine Tob Res. 2010;12(5):500-507. doi:10.1093/ntr/ntq039.
28. Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry. 1986;43(3):289-294.
29. Aubin HJ, Bobak A, Britton JR, et al. Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial. Thorax. 2008;63(8):717-724. doi:10.1136/thx.2007.090647.
30. Shiffman S, Ferguson SG. The effect of a nicotine patch on cigarette craving over the course of the day: results from two randomized clinical trials. Curr Med Res Opin. 2008;24(10):2795-2804. doi:10.1185/03007990802380341.
31. Jacob N, Berny C, Boyer JC, et al. Urinary cotinine and nicotine metabolites measurement. Ann Biol Clin (Paris). 2005;63(4):397-409.
32. Eng J. ROC Analysis: Web-Based Calculator for ROC Curves. Baltimore, MD: Johns Hopkins University; 2014. www.jrocfit.org. Accessed October 22, 2014.
33. Nunnally JC, Bernstein IH. Psychometric Theory. 3rd ed. New York, NY:McGraw-Hill; 1994.
34. Streiner D. Starting at the beginning: an introduction to coefficient alpha and internal consistency. J Pers Assess. 2003;80(1):99-103.
35. Etter JF. A comparison of the content-, construct- and predictive validity of the cigarette dependence scale and the Fagerström test for nicotine dependence. Drug Alcohol Depend. 2005;77(3):259-268.
36. Cronbach L. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16(3):297-334.
37. Chabrol H, Niezborala M, Chastan E, Montastruc JL, Mullet E. A study of the psychometric properties of the Fagestrom Test for Nicotine Dependence. Addict Behav. 2003;28(8):1441-1445.
38. Radzius A, Gallo JJ, Epstein DH, et al. A factor analysis of the Fagerström Test for Nicotine Dependence (FTND). Nicotine Tob Res. 2003;5(2):255-240.
39. Richardson CG, Ratner PA. A confirmatory factor analysis of the Fagerstrom Test for Nicotine Dependence. Addict Behav. 2005;30(4):697-709.
40. Nakajima M, al'Absi M, Dokam A, Alsoofi M, Khalil NS. An examination of the Fagerström Test for Nicotine Dependence among concurrent tobacco and khat users. J Psychoactive Drugs. 2012;44(5):437-441.
41. Baker TB, Piper ME, McCarthy DE, et al. Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence. Nicotine Tob Res. 2007;9(suppl 4):S555-S570. doi:10.1080/14622200701673480.
42. Frost-Pineda K, Muhammad-Kah R, Rimmer L, Liang Q. Predictors, indicators, and validated measures of dependence in menthol smokers. J Addict Dis. 2014;33(2):94-113. doi:10.1080/10550887.2014.9 09696.
43. Kwok TC, Taggar J, Cooper S, Lewis S, Coleman T. Nicotine dependence and biochemical exposure measures in the second trimester of pregnancy. Nicotine Tob Res. 2014;16(2):145-154. doi:10.1093/ntr/ntt127.
44. Etter JF, Duc TV, Perneger TV. Validity of the Fagerström test for nicotine dependence and of the Heaviness of Smoking Index among relatively light smokers. Addiction. 1999;94(2):269-281.
45. Burling AS, Burling TA. A comparison of self-report measures of nicotine dependence among male drug/alcohol-dependent cigarette smokers. Nicotine Tob Res. 2003;5(5):625-633.
46. Hughes JR, Oliveto AH, Riggs R, et al. Concordance of different measures of nicotine dependence: two pilot studies. Addict Behav. 2004;29(8):1527-1539.
47. Heil SH, Higgins ST, Mongeon JA, Badger GJ, Bernstein IM. Characterizing nicotine withdrawal in pregnant cigarette smokers. Exp Clin Psychopharmacol. 2006;14(2):165-170.
48. Ussher M, Etter JF, Giatras N, Coleman T. Tobacco withdrawal symptoms and urges to smoke in pregnant versus non-pregnant smokers. Addict Behav. 2012;37(12):1353-1357. doi:10.1016/j. addbeh.2012.07.008.
49. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 2002;4(2):149-159.